journal article·2026-06Open access

Engineering skin microphysiological systems for transdermal drug screening based on strategic model selection and quantitative prediction roadmaps

Jongwoo Ahn, Geonho Jin, Minji Cho, Minho Do, Jungho Ahn, Jihoon Ko, Seokyoung Bang

Abstract

As transdermal drug delivery systems (TDDS) gain increasing importance, the need for screening platforms that accurately recapitulate human skin physiology has become essential. Conventional static evaluation methods, such as Franz diffusion cells, remain limited in their ability to recapitulate in vivo dynamic transport, metabolism, and clearance processes. This review examines the technical significance and emerging applicability of skin microphysiological systems (MPS) as next-generation platforms for transdermal drug screening. We first outline the multilayered structure of the skin, principal permeation pathways, and key physiological determinants governing transdermal absorption, while critically assessing the limitations of conventional ex vivo and in vitro methods. We then systematically present the design principles, evaluation metrics, and representative applications of diverse skin MPS, classified by vascularization and flow conditions. Through this analysis, we highlight how skin MPS improve the accuracy of permeability assessment and enable more physiologically relevant evaluation of drug efficacy and toxicity. Importantly, we emphasize that the primary value of skin MPS lies not in maximal complexity, but in the strategic selection of model architecture tailored to specific research objectives. Finally, we discuss future directions toward quantitative prediction, including integration of skin MPS data with physiologically based pharmacokinetic (PBPK) models via in vitro – in vivo extrapolation (IVIVE), alongside key challenges related to structural fidelity, standardization, and regulatory translation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Advancements in Transdermal Drug Delivery · Skin Protection and Aging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Skin structure, function, and permeation
2. Anatomy and function of the skin
3. Penetration through the skin barrier10.1159/000441549 ↗
4. Transdermal drug delivery10.1038/nbt.1504 ↗
5. Sustainable and efficient skin absorption behaviour of transdermal drug: the effect of the release kinetics of permeation enhancer10.1016/j.ijpharm.2021.121377 ↗
6. Transdermal drug delivery system: an overview10.4103/0973-8398.104828 ↗
7. Appropriate use of transdermal drug delivery systems
8. Transdermal nicotine absorption handling e-cigarette refill liquids10.1016/j.yrtph.2015.11.014 ↗
9. Interstitial fluid-based wearable biosensors for minimally invasive healthcare and biomedical applications10.1038/s43246-024-00468-6 ↗
10. Transdermal delivery systems in cosmetics10.1186/s41702-020-0058-7 ↗
11. Inter-and intra-individual variability in human skin barrier function: a large scale retrospective study10.1016/j.tiv.2008.01.009 ↗
12. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models10.1016/j.addr.2007.07.004 ↗
13. Transdermal drug delivery in vitro using diffusion cells10.2174/092986712803306358 ↗
14. Recent advances in transdermal drug delivery systems: a review10.1186/s40824-021-00226-6 ↗
15. Comparison between Franz diffusion cell and a novel micro-physiological system for in vitro penetration assay using different skin models10.1016/j.slast.2021.12.006 ↗
16. Percutaneous absorption in diseased skin: an overview10.1002/jat.1773 ↗
17. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes10.1016/j.addr.2012.04.009 ↗
18. Skin barrier function10.1007/978-3-642-12264-4_4 ↗
19. The structure and function of skin
20. Development and homeostasis of the skin epidermis10.1101/cshperspect.a008383 ↗
21. Crosstalk in skin: melanocytes, keratinocytes, stem cells, and melanoma10.1007/s12079-016-0349-3 ↗
22. Structure and function of the epidermis related to barrier properties10.1016/j.clindermatol.2011.08.007 ↗
23. Epidermal structure and differentiation10.1016/j.cub.2020.01.004 ↗
24. Structure and function of the epidermis
25. Redefining the role of langerhans cells as immune regulators within the skin10.3389/fimmu.2017.01941 ↗
26. Stratum corneum lipid function
27. Basic physiology of the skin
28. Anatomy and physiology of the skin10.1097/JDN.0b013e3182274a98 ↗
29. Lineage identity and location within the dermis determine the function of papillary and reticular fibroblasts in human skin10.1016/j.jid.2018.07.033 ↗
30. The dynamic anatomy and patterning of skin10.1111/exd.12832 ↗
31. Defining dermal adipose tissue10.1111/exd.12450 ↗
32. Aging and homeostasis of the hypodermis in the age-related deterioration of skin function10.1038/s41419-024-06818-z ↗
33. Skin structure, physiology, and pathology in topical and transdermal drug delivery10.3390/pharmaceutics16111403 ↗
34. Transdermal drug delivery system: formulation aspects and evaluation
35. Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum10.1021/js980018w ↗
36. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum10.1016/j.ijpharm.2005.04.004 ↗
37. Transdermal drug delivery: penetration enhancement techniques10.2174/1567201052772915 ↗
38. Role of the appendageal pathway in the percutaneous absorption of pyridostigmine bromide in various vehicles10.1007/BF03190183 ↗
39. Drug delivery across the skin10.1517/13543784.6.12.1887 ↗
40. Interindividual variation in transdermal and oral drug deliveries10.1002/jps.23270 ↗
41. Skin deep: the basics of human skin structure and drug penetration
42. Skin penetration
43. Lipids and the epidermal permeability barrier10.1007/BF00417155 ↗
44. Epidermal lipids, membranes, and keratinization10.1111/j.1365-4362.1981.tb05278.x ↗
45. Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism10.1016/0168-3659(91)90111-P ↗
46. The impact of ageing on the barriers to drug delivery10.1016/j.jconrel.2012.01.020 ↗
47. Percutaneous absorption and inflammation in aged skin: a review10.1016/S0190-9622(94)70273-X ↗
48. Age-related changes in pharmacokinetics10.2174/138920011796504527 ↗
49. Roberts · 2008
50. Transdermal absorption of active substances from cosmetic vehicles10.1111/jocd.12873 ↗
51. Effects of occlusion: percutaneous absorption
52. Modeling temperature-dependent dermal absorption and clearance for transdermal and topical drug applications10.1208/s12248-020-00451-2 ↗
53. The effect of temperature on blood flow and deep temperature in the human forearm10.1113/jphysiol.1943.sp004009 ↗
54. Skin temperature: its role in thermoregulation10.1111/apha.12231 ↗
55. Advance and challenges in the treatment of skin diseases with the transdermal drug delivery system10.3390/pharmaceutics15082165 ↗
56. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties10.1002/jps.20773 ↗
57. Physicochemical properties of drugs and membrane permeability
58. Predicting skin permeability10.1023/A:1015810312465 ↗
59. The 500 dalton rule for the skin penetration of chemical compounds and drugs10.1034/j.1600-0625.2000.009003165.x ↗
60. Drug delivery to and through the skin10.1007/s13346-024-01614-w ↗
61. Separation methods for estimating octanol–water partition coefficients10.1016/j.jchromb.2003.08.032 ↗
62. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery10.4103/0250-474X.40340 ↗
63. Enhancement strategies for transdermal drug delivery systems: current trends and applications10.1007/s13346-021-00909-6 ↗
64. Amphiphilic transdermal permeation enhancers: structure-activity relationships10.2174/0929867054864822 ↗
65. Drug diffusion transport through human skin10.2478/ijame-2018-0055 ↗
66. Natural skin surface pH is on average below 5, which is beneficial for its resident flora10.1111/j.1467-2494.2006.00344.x ↗
67. pH profiles in human skin: influence of two in vitro test systems for drug delivery testing10.1016/S0939-6411(02)00125-X ↗
68. Evaluation of skin absorption of drugs from topical and transdermal formulations10.1590/s1984-82502016000300018 ↗
69. Transdermal patches: history, development and pharmacology10.1111/bph.13059 ↗
70. Formulation effects of topical emulsions on transdermal and dermal delivery10.1111/j.1468-2494.2008.00467.x ↗
71. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum10.3390/pharmaceutics7040438 ↗
72. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics10.1007/s11095-008-9742-9 ↗
73. Reconstructed epidermis versus human and animal skin in skin absorption studies10.1016/j.tiv.2005.04.004 ↗
74. Transdermal permeation of drugs in various animal species10.3390/pharmaceutics9030033 ↗
75. OECD test guideline 428—A method for in vitro percutaneous absorption measurement?
76. 2004
77. Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell10.1002/jps.2600740117 ↗
78. Validation of a flow-through diffusion cell for use in transdermal research10.1023/A:1016405506028 ↗
79. In vitro skin permeation techniques10.1016/0168-3659(92)90169-R ↗
80. Skin absorption: flow-through or static diffusion cells10.1016/0887-2333(94)90078-7 ↗
81. Optimizing in vitro skin permeation studies to obtain meaningful data in topical and transdermal drug delivery10.1208/s12249-025-03143-2 ↗
82. Improved barrier structure formation in air-exposed human keratinocyte culture systems10.1111/1523-1747.ep12371797 ↗
83. Comparison of synthetic membranes to heat-separated human epidermis in skin permeation studies in vitro10.3390/pharmaceutics13122106 ↗
84. Microfluidic skin‐on‐a‐chip models: toward biomimetic artificial skin10.1002/smll.202002515 ↗
85. Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review10.1007/s00204-022-03234-0 ↗
86. Permeability of the reconstructed human epidermis model episkin® in comparison to various human skin preparations10.1016/j.ejpb.2006.08.012 ↗
87. Microfluidic organs-on-chips10.1038/nbt.2989 ↗
88. Organs-on-chips at the frontiers of drug discovery10.1038/nrd4539 ↗
89. Modeling transdermal drug release10.1016/S0169-409X(01)00113-2 ↗
90. Design and evaluation of a skin-on-a-chip pumpless microfluidic device10.1038/s41598-023-34796-3 ↗
91. Design of an integrated microvascularized human skin-on-a-chip tissue equivalent model10.3389/fbioe.2022.915702 ↗
92. A microscale, full-thickness, human skin on a chip assay simulating neutrophil responses to skin infection and antibiotic treatments10.1039/C9LC00399A ↗
93. Human skin explant model for the investigation of topical therapeutics10.1038/s41598-020-78292-4 ↗
94. Skin-on-a-chip models: general overview and future perspectives10.1063/5.0046376 ↗
95. Establishment of 3D organotypic cultures using human neonatal epidermal cells10.1038/nprot.2006.448 ↗
96. Modeling of three-dimensional innervated epidermal like-layer in a microfluidic chip-based coculture system10.1038/s41467-023-37187-4 ↗
97. Interstitial flow and its effects in soft tissues10.1146/annurev.bioeng.9.060906.151850 ↗
98. Blood flow in the microcirculation10.1146/annurev-fluid-010816-060302 ↗
99. Microtechnology for mimicking in vivo tissue environment10.1007/s10439-011-0491-2 ↗
100. Comparison of biocompatibility and adsorption properties of different plastics for advanced microfluidic cell and tissue culture models10.1021/ac300771z ↗